References
- TjiangHLahootiHMcCorquodaleTParmarKRWallJREye and eyelid abnormalities are common in patients with Hashimoto’s thyroiditisThyroid201020328729020146657
- GopinathBMusselmanRAdamsCTaniJBeardNWallJRStudy of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves’ disease with and without ophthalmopathy – correlation with clinical featuresThyroid20061696797417042681
- SalviMZhangZGHaegertDPatients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalitiesJ Clin Endocrinol Metab199070189942294141
- McCorquodaleTLahootiHGopinathBWallJRLong-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathyClin Ophthalmol201261063107122888204
- EcksteinAKPlichtMLaxHThyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the diseaseJ Clin Endocrinol Metab20069193464347016835285
- PaschkeRVassartGLudgateMCurrent evidence for and against the TSH receptor being the common antigen in Graves’ disease and thyroid associated ophthalmopathyClin Endocrinol (Oxf)19954265655697634495
- BahnRSClinical review 157: Pathophysiology of Graves’ ophthalmopathy: the cycle of diseaseJ Clin Endocrinol Metab20038851939194612727937
- WallJRThe TSH-Receptor and Thyroid-Associated Ophthalmopathy – a Convenient Hypothesis with too many Exceptions to be trueInt J Endocrinol Metab200724951
- LyttonSDLiYOlivoPDKohnLDKahalyGJNovel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulinsClin Exp Immunol2010162343844621070207
- LyttonSDPontoKAKanitzMMatheisNKohnLDKahalyGJA novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves’ orbitopathyJ Clin Endocrinol Metab20109552123213120237164
- LyttonSDKahalyGJBioassays for TSH-receptor autoantibodies: an updateAutoimmun Rev201010211612220807591
- NuneryWRMartinRTHeinzGWGavinTJThe association of cigarette smoking with clinical subtypes of ophthalmic Graves’ diseaseOphthal Plast Reconstr Surg1993927782
- MouritsMPKoornneefLWiersingaWMPrummelMFBerghoutAvan der GaagRClinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approachBr J Ophthalmol19897386396442765444
- WernerSCClassification of the eye changes of Graves’ diseaseAm J Ophthalmol19696846466485394450
- GopinathBMaGWallJREye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditisThyroid200717111123112917887926
- De BellisASansoneDCoronellaCSerum antibodies to collagen XIII: a further good marker of active Graves’ ophthalmopathyClin Endocrinol (Oxf)2005621242915638866
- GopinathBMusselmanRAdamsCLTaniJBeardNWallJRStudy of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves’ disease with and without ophthalmopathy: correlation with clinical featuresThyroid2006161096797417042681
- WeetmanAPGraves’ diseaseN Engl J Med2000343171236124811071676
- GerdingMNvan der MeerJWBroeninkMBakkerOWiersingaWMPrummelMFAssociation of thyrotrophin receptor antibodies with the clinical features of Graves’ ophthalmopathyClin Endocrinol (Oxf)200052326727110718823
- BurchHBWartofskyLGraves’ ophthalmopathy: current concepts regarding pathogenesis and managementEndocr Rev19931467477938119236
- De BellisASansoneDCoronellaCSerum antibodies to collagen XIII: a further good marker of active Graves’ ophthalmopathyClin Endocrinol (Oxf)2005621242915638866